Bank of New York Mellon
ELOX

Bank of New York Mellon’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bank of New York Mellon’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,635
Closed -$25K – 4602
2022
Q3 		$25K Hold
3,635
– – ﹤0.01% 4424
2022
Q2 		$39K Sell
3,635
-22
-0.6% -$304 ﹤0.01% 4397
2022
Q1 		$82K Hold
3,657
– – ﹤0.01% 4443
2021
Q4 		$103K Buy
3,657
+1,754
+92% +$76.5K ﹤0.01% 4398
2021
Q3 		$124K Buy
1,903
+1,605
+539% +$99K ﹤0.01% 4291
2021
Q2 		$24K Sell
298
-1,484
-83% -$124K ﹤0.01% 4380
2021
Q1 		$237K Sell
1,782
-7
-0.4% -$1.07K ﹤0.01% 4001
2020
Q4 		$285K Sell
1,789
-85
-5% -$10.4K ﹤0.01% 3850
2020
Q3 		$197K Buy
1,874
+253
+16% +$30.3K ﹤0.01% 3853
2020
Q2 		$196K Sell
1,621
-95
-6% -$10.8K ﹤0.01% 3802
2020
Q1 		$134K Hold
1,716
– – ﹤0.01% 3825
2019
Q4 		$505K Buy
1,716
+111
+7% +$22.4K ﹤0.01% 3595
2019
Q3 		$290K Buy
1,605
+41
+3% +$11.7K ﹤0.01% 3790
2019
Q2 		$624K Sell
1,564
-186
-11% -$78.3K ﹤0.01% 3494
2019
Q1 		$818K Buy
1,750
+72
+4% +$35K ﹤0.01% 3303
2018
Q4 		$806K Buy
1,678
+95
+6% +$52.4K ﹤0.01% 3228
2018
Q3 		$1.08M Buy
1,583
+63
+4% +$40.3K ﹤0.01% 3223
2018
Q2 		$1.04M Buy
+1,520
New +$985K ﹤0.01% 3224

Other funds holding ELOX

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $8.04B AUM 44.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of New York Mellon's ELOX Position: Q4 2022 in Review

Bank of New York Mellon sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q4 2022, closing a stake of 3,635 shares — an estimated $25K sold.

Bank of New York Mellon first reported a position in ELOX in Q2 2018 and held it in 18 quarters. The position peaked at $1.08M in Q3 2018. 19 funds tracked by Wall St. Rank hold ELOX as of Q4 2022.

  • Bank of New York Mellon reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 3,635 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $25K.
  • Bank of New York Mellon first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q2 2018 and held it in 18 quarters.
  • Bank of New York Mellon's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $1.08M in Q3 2018.
  • 19 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.